Clinical Trial Update: Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

A Phase 3 efficacy and safety study evaluating methylphenidate hydrochloride extended-release in adults with childhood-onset ADHD; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Attention Deficit/Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2014-04-29